Cognition Therapeutics, Inc. (CGTX)

CIK 0001455365 · Healthcare · Biotechnology

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q2-2026 8-K (2026-08-06) · 99.1
Q1-2026 8-K (2026-05-07) · 99.1
Latest FY-2025 8-K (2026-03-26) · 99.1 · 99.2
Q3-2025 8-K (2025-11-06) · 99.1
Q2-2025 8-K (2025-08-07) · 99.1
Q1-2025 8-K (2025-05-07) · 99.1
FY-2024 8-K (2025-03-20) · 99.1
Q3-2024 8-K (2024-11-13) · 99.1
Q2-2024 8-K (2024-08-08) · 99.1
Q1-2024 8-K (2024-05-07) · 99.1
FY-2023 8-K (2024-03-26) · 99.1  |  8-K (2024-03-11)
Q3-2023 8-K (2023-11-02) · 99.1

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Document and Entity Information
Statements
Balance Sheets
—
Consolidated Balance Sheets
Balance Sheets (P)
—
Consolidated Balance Sheets (P)
Consolidated Statements of Operations and Comprehensive Loss
Statements of Operations and Comprehensive Loss
—
Consolidated Statements of Stockholders' Equity
Statements of Stockholders' Equity
—
Consolidated Statements of Cash Flows
Consolidated Statements of Stockholders' Equity (P)
Statements of Cash Flows
—
Notes
Accrued Expenses
Commitments and Contingencies
Cybersecurity Risk Management and Strategy Disclosure
—
Description of Business and Financial Condition
Equity-based Compensation
Financial Instruments and Fair Value Measurements
Income Taxes
—
Insider Trading Arrangements
Insider Trading Policies and Procedures
—
Net Loss Per Share
Other Current Liabilities
Pay Vs Performance Disclosure
Property and Equipment
—
Retirement Plan
—
Segment Reporting
Stockholders' Equity
Subsequent Events
—
Summary of Significant Accounting Policies